Oramed Pharmaceuticals
ORMP
#9082
Rank
C$0.13 B
Marketcap
$3.40
Share price
-2.04%
Change (1 day)
-19.50%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): C$33.14 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of C$10.1 Million, an increase over its 2022 earnings that were of -C$51.95 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$33.14 M228.05%
2023 C$10.1 M-119.45%
2022 -C$51.95 Million39.17%
2021 -C$37.33 Million73.93%
2020 -C$21.46 Million18.53%
2019 -C$18.11 Million-16.62%
2018 -C$21.72 Million38.32%
2017 -C$15.7 Million12.51%
2016 -C$13.96 Million25.01%
2015 -C$11.17 Million18.18%
2014 -C$9.45 Million39.72%
2013 -C$6.76 Million46.4%
2012 -C$4.62 Million128.32%
2011 -C$2.03 Million-51.47%
2010 -C$4.17 Million35.21%
2009 -C$3.09 Million
2007 -C$4.85 Million607.04%
2006 -C$0.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.71 Billion-2,113.66%๐Ÿ‡บ๐Ÿ‡ธ USA
C$25.30 B 72,308.80%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
C$10.50 B 29,960.63%๐Ÿ‡ซ๐Ÿ‡ท France
C$21.44 M-38.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-C$0.31 Billion-978.11%๐Ÿ‡บ๐Ÿ‡ธ USA